Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Farmalogg AS
AS
Active
Org 896031082
Slemdalsveien 1, 0369
Oslo
Other software publishing
·
NACE 5829
Est. 2010 · 15 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Other software publishing
/
Farmalogg AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
24M
18M
12M
6M
0M
2021: 15M
15M
2021
2022: 16M (+7% vs 2021)
16M
+7%
2022
2023: 17M (+6% vs 2022)
17M
+6%
2023
2024: 18M (+6% vs 2023)
18M
+6%
2024
2025: 19M (+6% vs 2024)
19M
+6%
2025
EBITDA
NOK millions
7M
6M
4M
2M
0M
2021: 5M
5M
2021
2022: 5M (0% vs 2021)
5M
0%
2022
2023: 5M (0% vs 2022)
5M
0%
2023
2024: 4M (-20% vs 2023)
4M
-20%
2024
2025: 6M (+50% vs 2024)
6M
+50%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
18 561
17 796
16 858
15 902
15 373
Staff expenses
−6 614
−6 281
−5 360
−5 541
−5 239
EBITDA
6 479
4 091
5 338
4 940
4 923
Depreciation & amort.
−5
−17
−17
−13
−145
EBIT
6 474
4 074
5 321
4 927
4 779
Net financials
466
592
400
136
14
Profit before tax
6 939
4 666
5 722
5 063
4 793
Tax
1 534
1 026
1 259
1 114
1 049
Net profit
5 405
3 640
4 463
3 949
3 744
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
17 053
12 783
12 132
9 837
9 463
Equity
10 258
7 853
6 213
4 250
2 740
Long-term debt
0
0
0
0
0
Short-term debt
6 795
4 930
5 920
5 587
6 723
Total debt
6 795
4 930
5 920
5 587
6 723
Financial ratios
5-year trend
EBITDA margin
34,9 %
This company
15,8 %
Market median
This company
Market median
121% above market
2021
2025
Equity ratio
60,2 %
This company
38,2 %
Market median
This company
Market median
58% above market
2021
2025
Return on equity
52,7 %
This company
18,4 %
Market median
This company
Market median
186% above market
2021
2025
Net profit margin
29,1 %
This company
8,1 %
Market median
This company
Market median
259% above market
2021
2025
Asset turnover
1,09×
This company
1,12×
Market median
This company
Market median
3% below market
2021
2025
Debt / equity
0,66×
This company
0,62×
Market median
This company
Market median
6% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Farmalogg AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
